-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FMVRYoyJpLLfsw5OGs+eEikh2DFyz4hiEk2vzXat3ipYRWXfhStdc/2xrxjRwUns uZDkAyDba4LEADXFDoFEtw== 0000950117-02-002531.txt : 20021031 0000950117-02-002531.hdr.sgml : 20021031 20021031090512 ACCESSION NUMBER: 0000950117-02-002531 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20021031 ITEM INFORMATION: FILED AS OF DATE: 20021031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 02803932 BUSINESS ADDRESS: STREET 1: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07608 BUSINESS PHONE: 2013935000 MAIL ADDRESS: STREET 1: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07601 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 8-K 1 a33611.txt QUEST DIAGNOSTICS SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ----------------------------- Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ----------------------------- Date of Report (Date of earliest event reported): October 31, 2002 Quest Diagnostics Incorporated (Exact name of Registrant as specified in its charter) Delaware 1-12215 16-1387862 (State or other jurisdiction Commission File Number (I.R.S. Employer of incorporation) Identification Number)
----------------------------- One Malcolm Avenue Teterboro, New Jersey 07608 (201) 393-5000 (Address of principal executive offices and telephone number, including area code) ----------------------------- Item 9. Regulation FD Disclosure. ------------------------- On October 31, 2002, Kenneth W. Freeman, the Chief Executive Officer of Quest Diagnostics Incorporated, and Robert A. Hagemann, the Chief Financial Officer of Quest Diagnostics Incorporated, submitted to the Securities and Exchange Commission sworn statements pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. Signature Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 31, 2002 QUEST DIAGNOSTICS INCORPORATED By: s/Leo C. Farrenkopf, Jr. ------------------------------------ Name: Leo C. Farrenkopf, Jr. Title: Vice President and Secretary Exhibit Index Exhibit 99.1 Statement Pursuant to 18. U.S.C. 'SS' 1350 of Chief Executive Officer dated October 31, 2002 Exhibit 99.2 Statement Pursuant to 18. U.S.C. 'SS' 1350 of Chief Financial Officer dated October 31, 2002 STATEMENT OF DIFFERENCES The section symbol shall be expressed as.........................'SS' EX-99 3 ex99-1.txt EXHIBIT 99.1 Exhibit 99.1 STATEMENT PURSUANT TO 18 U.S.C. 'SS' 1350 Pursuant to 18 U.S.C. 'SS' 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended September 30, 2002 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 'SS' 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated. Dated: October 31, 2002 s/ Kenneth W. Freeman ------------------------------- Kenneth W. Freeman Chief Executive Officer EX-99 4 ex99-2.txt EXHIBIT 99.2 Exhibit 99.2 STATEMENT PURSUANT TO 18 U.S.C. 'SS' 1350 Pursuant to 18 U.S.C. 'SS' 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended September 30, 2002 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 'SS' 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated. Date: October 31, 2002 s/ Robert A. Hagemann ------------------------------- Robert A. Hagemann Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----